Scarica l'app Stockscreener
9.5058
2.04%
0.1758
Immunome Inc Borsa (IMNM) Ultime notizie
Victory Capital Management Inc. Boosts Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Wedbush Has Bullish Outlook for Immunome FY2024 Earnings - MarketBeat
Leerink Partnrs Decreases Earnings Estimates for Immunome - MarketBeat
FY2024 EPS Estimates for Immunome Lowered by Leerink Partnrs - Defense World
Immunome Inc. Announces Third Quarter 2024 Financial Results and Pipeline Progress - Defense World
Immunome Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Immunome (NASDAQ:IMNM) Stock Price Down 7% After Analyst Downgrade - Defense World
T. Rowe Price Investment Management, Inc. Expands Stake in Immun - GuruFocus.com
Piper Sandler maintains overweight on IMNM with $21 target By Investing.com - Investing.com Canada
Piper Sandler maintains overweight on IMNM with $21 target - Investing.com India
Immunome Reports Third Quarter 2024 Financial Results and Provides Business Update - BioSpace
Janus Henderson Group's Strategic Acquisition of Immunome Inc Sh - GuruFocus.com
Immunome (NASDAQ:IMNM) Shares Down 7% Following Analyst Downgrade - MarketBeat
Piper Sandler Cuts Immunome (NASDAQ:IMNM) Price Target to $21.00 - MarketBeat
Immunome price target lowered to $21 from $23 at Piper Sandler - TipRanks
Immunome, Inc. Reports Q3 2024 Financial Results - TipRanks
Immunome Inc (IMNM) Q3 2024 Earnings: Revenue Surpasses Estimates at $2.91M, GAAP EPS Misses at -$0.78 - GuruFocus.com
Immunome, Inc. (IMNM) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Immunome, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Immunome Reports $47.1M Q3 Loss, Advances Cancer Pipeline with Strong Cash Position | IMNM Stock News - StockTitan
(IMNM) Technical Pivots with Risk Controls - Stock Traders Daily
Immunome earnings missed by $0.24, revenue topped estimates - Investing.com Canada
FMR LLC's Strategic Acquisition of Immunome Inc Shares - GuruFocus.com
Immunome (NASDAQ:IMNM) Shares Gap Up – Still a Buy? - Defense World
Stephens & Co. Initiates Coverage of Immunome (IMNM) with Overweight Recommendation - MSN
Analyst Expectations For Immunome's Future - Benzinga
Immunome (NASDAQ:IMNM) Shares Gap UpTime to Buy? - MarketBeat
Immunome (NASDAQ:IMNM) Now Covered by Stephens - MarketBeat
Immunome, Inc. (NASDAQ:IMNM) Stake Reduced by Wealth Enhancement Advisory Services LLC - Defense World
Immunome to Present at Guggenheim’s Inaugural Healthcare Innovation Conference - The Bakersfield Californian
Immunome CEO to Present at Guggenheim's First Healthcare Innovation Conference | IMNM Stock News - StockTitan
Vanguard Group Inc's Strategic Acquisition of Immunome Inc Shares - GuruFocus.com
Immunome (NASDAQ:IMNM) Trading Up 8.7%Time to Buy? - MarketBeat
Learn to Evaluate (IMNM) using the Charts - Stock Traders Daily
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan
Immunome, Inc. (NASDAQ:IMNM) Receives $29.00 Average PT from Brokerages - MarketBeat
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Rating of “Buy” by Analysts - Defense World
Immunome (NASDAQ: IMNM) Acquires Zentalis Pharmaceuticals’ Licensed Assets IMMUNOME, Inc. made a recent significant move on October 25, 2024, by acquiring Zentalis Pharmaceuticals, Inc.’s Licensed Assets. This acquisition was carried out thr - Defense World
Immunome Advances with Strategic Asset Acquisition and Agreement - Yahoo Finance
Immunome Presents Compelling Preclinical Data Demonstrating Robust Anti-Tumor Activity for IM-1021 - Business Wire
Immunome, Inc. (NASDAQ:IMNM) Short Interest Down 15.2% in October - MarketBeat
Immunome's (IMNM) Outperform Rating Reiterated at Wedbush - MarketBeat
Immunome to Present Poster Highlighting Preclinical Evaluation of IM-1021, a ROR1-Targeted Antibody Drug Conjugate, at the 36th EORTC-NCI-AACR Symposium - The Bakersfield Californian
IMNMImmunome, Inc. Latest Stock News & Market Updates - StockTitan
Immunome (IMNM) Price Target Increased by 179.17% to 34.17 - MSN
Cubist Systematic Strategies LLC Reduces Stake in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Cubist Systematic Strategies LLC Decreases Position in Immunome, Inc. (NASDAQ:IMNM) - MarketBeat
Understanding the Risks of Investing in Immunome Inc (IMNM) - Knox Daily
Financial Metrics Exploration: Understanding Immunome Inc (IMNM) Through Ratios - The Dwinnex
Sei Investments Co. Cuts Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World
(IMNM) Investment Analysis and Advice - Stock Traders Daily
Insider Selling: Rosett Max, Immunome Inc [IMNM] Chief Financial Officer divested 14,380 shares - Knox Daily
Did Immunome Inc (IMNM) perform well in the last session? - US Post News
The Manufacturers Life Insurance Company Has $2.02 Million Holdings in Immunome, Inc. (NASDAQ:IMNM) - MarketBeat
Immunome (NASDAQ:IMNM) Shares Down 6.1%Here's Why - MarketBeat
Immunome Inc. launches new inducement plan By Investing.com - Investing.com South Africa
Immunome names Roee Shahar as EVP, Commercial By Investing.com - Investing.com South Africa
Immunome (NASDAQ:IMNM) Trading Up 3.5% – Here’s What Happened - Defense World
Immunome (NASDAQ:IMNM) Trading 3.5% HigherWhat's Next? - MarketBeat
Immunome Inc. launches new inducement plan - Investing.com
1.80%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):